Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights
August 03 2022 - 4:16PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will host a virtual Investor Event on Sunday, August 28,
2022, at 7:00 p.m. CET/ 1:00 p.m. ET to discuss data from the
AXIOMATIC-SSP Phase 2 trial of milvexian in secondary stroke
prevention presented at the European Society of Cardiology Congress
2022 in Barcelona, Spain.
Company executives will provide an overview of data presented
and address questions from investors and analysts.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Material related
to the company’s presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220803005877/en/
Bristol Myers Squibb
Media: media@bms.com
Investor Relations: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024